Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cephalalgia. 2011 Oct;31(13):1381–1404. doi: 10.1177/0333102411419022

Table 2.

Allele and genotype frequencies as well as Hardy-Weinberg Equilibrium according to the investigated polymorphisms

TNF-alpha -308G>A (rs1800629) polymorphism

Allele frequencies, n (%) Genotype frequencies, n (%)

Author Participants Disease status Study size HWE G A GG GA AA
Trabace 2002 (20) all controls 101 0.052 189 (93.6) 13 (6.4) 90 (89.1) 9 (8.9) 2 (2.0)
migraine 79 1.000 146 (92.4) 12 (7.6) 67 (84.8) 12 (15.2) 0 (0.0)
MA 32 1.000 57 (89.1) 7 (10.9) 25 (78.1) 7 (21.9) 0 (0.0)
MO 47 1.000 89 (94.7) 5 (5.3) 42 (89.4) 5 (10.6) 0 (0.0)

females controls 45 0.116 85 (94.4) 5 (5.6) 41 (91.1) 3 (6.7) 1 (2.2)

migraine 62 1.000 114 (91.9) 10 (8.1) 52 (83.9) 10 (16.1) 0 (0.0)
MA 27 1.000 48 (88.9) 6 (11.1) 21 (77.8) 6 (22.2) 0 (0.0)
MO 35 1.000 66 (94.3) 4 (5.7) 31 (88.6) 4 (11.4) 0 (0.0)

males controls 56 0.234 104 (92.9) 8 (7.1) 49 (87.5) 6 (10.7) 1 (1.8)
migraine 17 1.000 32 (94.1) 2 (5.9) 15 (88.2) 2 (11.8) 0 (0.0)
MA 5 1.000 9 (90.0) 1 (10.0) 4 (80.0) 1 (20.0) 0 (0.0)
MO 12 1.000 23 (95.8) 1 (4.2) 11 (91.7) 1 (8.3) 0 (0.0)

Rainero 2004 (16) all controls 306 0.693 502 (82.0) 110 (18.0) 207 (67.6) 88 (28.8) 11 (3.6)
migraine 299 1.000 554 (92.6) 44 (7.4) 256 (85.6) 42 (14.0) 1 (0.3)
MA 38 1.000 66 (86.8) 10 (13.2) 28 (73.7) 10 (26.3) 0 (0.0)
MO 261 1.000 488 (93.5) 34 (6.5) 228 (87.4) 32 (12.3) 1 (0.4)

females controls 231 1.000 382 (82.7) 80 (17.3) 158 (68.4) 66 (28.6) 7 (3.0)
migraine 215 0.611 401 (93.3) 29 (6.7) 186 (86.5) 29 (13.5) 0 (0.0)

males controls 75 0.475 120 (80.0) 30 (20.0) 49 (65.3) 22 (29.3) 4 (5.3)
migraine 84 0.504 153 (91.1) 15 (8.9) 70 (83.3) 13 (15.5) 1 (1.2)

Herken 2005 (23) all controls 62 1.000 115 (92.7) 9 (7.3) 53 (85.5) 9 (14.5) 0 (0.0)
migraine 60 0.170 113 (94.2) 7 (5.8) 54 (90.0) 5 (8.3) 1 (1.7)
MA 40 1.000 76 (95.0) 4 (5.0) 36 (90.0) 4 (10.0) 0 (0.0)
MO 20 0.079 37 (92.5) 3 (7.5) 18 (90.0) 1 (5.0) 1 (5.0)

Mazaheri 2006 (15) all controls 183 0.0004 274 (74.9) 92 (25.1) 94 (51.4) 86 (47) 3 (1.6)
MO 221 <0.0001 265 (60) 177 (40) 51 (23.1) 163 (73.8) 7 (3.2)

females controls 123 0.001 191 (77.6) 55 (22.4) 68 (55.3) 55 (44.7) 0 (0.0)
MO 196 <0.0001 233 (59.4) 159 (40.6) 44 (22.4) 145 (74) 7 (3.6)

males controls 60 0.141 83 (69.2) 37 (30.8) 26 (43.3) 31 (51.7) 3 (5.0)
MO 25 0.007 32 (64.0) 18 (36.0) 7 (28.0) 18 (72.0) 0 (0.0)

Lee 2007 (21) all/females controls 382 0.158 717 (93.8) 47 (6.2) 338 (88.5) 41 (10.7) 3 (0.8)
migraine 439 0.716 815 (92.8) 63 (7.2) 377 (85.9) 61 (13.9) 1 (0.2)
MA 65 1.000 119 (91.5) 11 (8.5) 54 (83.1) 11 (16.9) 0 (0.0)
MO 327 1.000 608 (93.0) 46 (7.0) 282 (86.2) 44 (13.5) 1 (0.3)

Asuni 2009 (19) all controls 278 0.560 526 (94.6) 30 (5.4) 249 (89.6) 28 (10.1) 1 (0.4)
MO 299 0.476 570 (95.3) 28 (4.7) 272 (91.0) 26 (8.7) 1 (0.3)

females controls 144 1.000 273 (94.8) 15 (5.2) 129 (89.6) 15 (10.4) 0 (0.0)
MO 261 0.452 497 (95.2) 25 (4.8) 237 (90.8) 23 (8.8) 1 (0.4)

males controls 134 0.333 253 (94.4) 15 (5.6) 120 (89.6) 13 (9.7) 1 (0.7)
MO 38 1.000 73 (96.1) 3 (3.9) 35 (92.1) 3 (7.9) 0 (0.0)

Schürks 2009 (17) all/females controls 20,425 0.559 33,771 (82.7) 7079 (17.3) 13947 (68.3) 5877 (28.8) 601 (2.9)
migraine 4577 0.094 7531 (82.3) 1623 (17.7) 3081 (67.3) 1369 (29.9) 127 (2.8)
MA 1275 0.420 2060 (80.8) 490 (19.2) 827 (64.9) 406 (31.8) 42 (3.3)
MO 1951 0.868 3240 (83.0) 662 (17.0) 1346 (69.0) 548 (28.1) 57 (2.9)

Ghosh 2010 (14) all controls 216 0.557 406 (94.0) 26 (6.0) 191 (88.4) 24 (11.1) 1 (0.5)
migraine 216 0.235 391 (90.5) 41 (9.5) 175 (81.0) 41 (19.0) 0 (0.0)
MA 84 0.595 149 (88.7) 19 (11.3) 65 (77.4) 19 (22.6) 0 (0.0)
MO 132 0.604 242 (91.7) 22 (8.3) 110 (83.3) 22 (16.7) 0 (0.0)

females controls 152 0.446 285 (93.8) 19 (6.3) 134 (88.2) 17 (11.2) 1 (0.7)
migraine 152 0.363 273 (89.8) 31 (10.2) 121 (79.6) 31 (20.4) 0 (0.0)
MA 63 0.594 109 (86.5) 17 (13.5) 46 (73.0) 17 (27.0) 0 (0.0)
MO 89 1.000 164 (92.1) 14 (7.9) 75 (84.3) 14 (15.7) 0 (0.0)

males controls 64 1.000 121 (94.5) 7 (5.5) 57 (89.1) 7 (10.9) 0 (0.0)
migraine 64 1.000 118 (92.2) 10 (7.8) 54 (84.4) 10 (15.6) 0 (0.0)
MA 21 1.000 40 (95.2) 2 (4.8) 19 (90.5) 2 (9.5) 0 (0.0)
MO 43 1.000 78 (90.7) 8 (9.3) 35 (81.4) 8 (18.6) 0 (0.0)

Yilmaz 2010 (18) all controls 96 0.590 174 (90.6) 18 (9.4) 79 (82.3) 16 (16.7) 1 (1.0)
MO 67 0.233 97 (72.4) 37 (27.6) 37 (55.2) 23 (34.3) 7 (10.4)

females controls 83 0.455 152 (91.6) 14 (8.4) 70 (84.3) 12 (14.5) 1 (1.2)
MO 57 0.308 83 (72.8) 31 (27.2) 32 (56.1) 19 (33.3) 6 (10.5)

males controls 13 1.000 22 (84.6) 4 (15.4) 9 (69.2) 4 (30.8) 0 (0.0)
MO 10 1.000 14 (70.0) 6 (30.0) 5 (50.0) 4 (40.0) 1 (10.0)

Pappa 2010 (22) all controls 178 0.680 321 (90.2) 35 (9.8) 145 (81.5) 31 (17.4) 2 (1.1)
MO 103 1.000 192 (93.2) 14 (6.8) 89 (86.4) 14 (13.6) 0 (0)

females controls 60 0.516 107 (89.2) 13 (10.8) 48 (80.0) 11 (18.3) 1 (1.7)
MO 57 1.000 105 (92.1) 9 (7.9) 48 (84.2) 9 (15.8) 0 (0.0)

males controls 118 1.000 214 (90.7) 22 (9.3) 97 (82.2) 20 (16.9) 1 (0.8)
MO 46 1.000 87 (94.6) 5 (5.4) 41 (89.1) 5 (10.9) 0 (0.0)

TNF-beta 252A>G (rs909253) polymorphism

Allele frequencies, n (%) Genotype frequencies, n (%)

Author Participants Disease status Study size HWE A G AA AG GG

Trabace 2002 (20) all controls 101 0.404 124 (61.4) 78 (38.6) 40 (39.6) 44 (43.6) 17 (16.8)
migraine 77 0.546 115 (74.7) 39 (25.3) 44 (57.1) 27 (35.1) 6 (7.8)
MA 30 0.106 41 (68.3) 19 (31.7) 16 (53.3) 9 (30.0) 5 (16.7)
MO 47 0.656 74 (78.72) 20 (21.28) 28 (59.57) 18 (38.30) 1 (2.13)

females controls 43 0.391 67 (77.9) 19 (22.1) 27 (62.8) 13 (30.2) 3 (7.0)
migraine 60 0.345 87 (72.5) 33 (27.5) 33 (55.0) 21 (35.0) 6 (10.0)
MA 25 0.230 31 (62.0) 19 (38.0) 11 (44.0) 9 (36.0) 5 (20.0)
MO 35 1.000 56 (80.0) 14 (20.0) 22 (62.9) 12 (34.3) 1 (2.9)

males controls 58 0.328 84 (72.4) 32 (27.6) 32 (55.2) 20 (34.5) 6 (10.3)
migraine 17 1.000 28 (82.4) 6 (17.6) 11 (64.7) 6 (35.3) 0 (0.0)
MA 5 --- 10 (100.0) 0 (0.0) 5 (100.0) 0 (0.0) 0 (0.0)
MO 12 0.536 18 (75.0) 6 (25.0) 6 (50.0) 6 (50.0) 0 (0.0)

Lee 2007 (21) all/females controls 382 0.915 439 (57.5) 325 (42.5) 125 (32.7) 189 (49.5) 68 (17.8)
migraine 439 0.070 467 (53.2) 411 (46.8) 134 (30.5) 199 (45.3) 106 (24.1)
MA 65 0.803 69 (53.1) 61 (46.9) 19 (29.2) 31 (47.7) 15 (23.1)
MO 327 0.118 347 (53.1) 307 (46.9) 99 (30.3) 149 (45.6) 79 (24.2)

Asuni 2009 (19) all controls 278 0.597 482 (86.7) 74 (13.3) 210 (75.5) 62 (22.3) 6 (2.2)
MO 299 1.000 488 (81.6) 110 (18.4) 199 (66.6) 90 (30.1) 10 (3.3)

females controls 144 1.000 244 (84.7) 44 (15.3) 103 (71.5) 38 (26.4) 3 (2.1)
MO 261 1.000 429 (82.2) 93 (17.8) 176 (67.4) 77 (29.5) 8 (3.1)

males controls 134 0.207 238 (88.8) 30 (11.2) 107 (79.9) 24 (17.9) 3 (2.2)
MO 38 1.000 59 (77.6) 17 (22.4) 23 (60.5) 13 (34.2) 2 (5.3)

Schürks 2009 (17) all/females controls 19,269 0.557 25,570 (66.4) 12,968 (33.6) 8501 (44.1) 8568 (44.5) 2200 (11.4)
migraine 4332 0.564 5738 (66.2) 2926 (33.8) 1891 (43.7) 1956 (45.2) 485 (11.2)
MA 1213 0.315 1597 (65.8) 829 (34.2) 517 (42.6) 563 (46.4) 133 (11.0)
MO 1824 0.528 2420 (66.3) 1228 (33.7) 809 (44.4) 802 (44.0) 213 (11.7)

Ghosh 2010 (14) all controls 216 0.858 328 (75.9) 104 (24.1) 125 (57.9) 78 (36.1) 13 (6.0)
migraine 216 0.354 328 (75.9) 104 (24.1) 127 (58.8) 74 (34.3) 15 (6.9)
MA 84 0.162 125 (74.4) 43 (25.6) 49 (58.3) 27 (32.1) 8 (9.5)
MO 132 1.000 203 (76.9) 61 (23.1) 78 (59.1) 47 (35.6) 7 (5.3)

females controls 152 0.467 241 (79.3) 63 (20.7) 97 (63.8) 47 (30.9) 8 (5.3)
migraine 152 0.359 234 (77.0) 70 (23.0) 92 (60.5) 50 (32.9) 10 (6.6)
MA 63 0.092 96 (76.2) 30 (23.8) 39 (61.9) 18 (28.6) 6 (9.5)
MO 89 1.000 138 (77.5) 40 (22.5) 53 (59.6) 32 (36.0) 4 (4.5)

males controls 64 0.563 87 (68.0) 41 (32.0) 28 (43.8) 31 (48.4) 5 (7.8)
migraine 64 0.753 94 (73.4) 34 (26.6) 35 (54.7) 24 (37.5) 5 (7.8)
MA 21 1.000 29 (69.0) 13 (31.0) 10 (47.6) 9 (42.9) 2 (9.5)
MO 43 0.681 65 (75.6) 21 (24.4) 25 (58.1) 15 (34.9) 3 (7.0)

Pappa 2010 (22) all controls 178 0.503 279 (78.4) 77 (21.6) 111 (62.4) 57 (32.0) 10 (5.6)
MO 103 0.747 167 (81.1) 39 (18.9) 68 (66.0) 31 (30.1) 4 (3.9)

females controls 60 0.709 95 (79.2) 25 (20.8) 38 (63.3) 19 (31.7) 3 (5.0)
MO 57 1.000 94 (82.5) 20 (17.5) 38 (66.6) 18 (31.6) 1 (1.8)

males controls 118 0.590 184 (78.0) 52 (22.0) 73 (61.9) 38 (32.2) 7 (5.9)
MO 46 0.366 73 (79.3) 19 (20.7) 30 (65.2) 13 (28.3) 3 (6.5)

TNF-alpha -238G>A (rs361525) polymorphism

- Allele frequencies, n (%) Genotype frequencies, n (%)

Author Participants Disease status Study size HWE G A GG GA AA

Schürks 2009 (17) all/females controls 20,425 0.006 38,780 (94.9) 2070 (5.1) 18,427 (90.2) 1926 (9.4) 72 (0.4)
migraine 4577 0.431 8705 (95.1) 449 (4.9) 4136 (90.4) 433 (9.5) 8 (0.2)
MA 1275 0.763 2422 (95.0) 128 (5.0) 1149 (90.1) 124 (9.7) 2 (0.2)
MO 1951 0.784 3730 (95.6) 172 (4.4) 1783 (91.4) 164 (8.4) 4 (0.2)

Pappa 2010 (22) all controls 178 1.000 348 (97.8) 8 (2.2) 170 (95.5) 8 (4.5) 0 (0.0)
MO 103 1.000 199 (96.6) 7 (3.4) 96 (93.2) 7 (6.8) 0 (0.0)

females controls 60 1.000 119 (99.2) 1 (0.8) 59 (98.3) 1 (1.7) 0 (0.0)
MO 57 1.000 111 (97.4) 3 (2.6) 54 (94.7) 3 (5.3) 0 (0.0)

males controls 118 1.000 229 (97.0) 7 (3.0) 111 (94.1) 7 (5.9) 0 (0.0)
MO 46 1.000 88 (95.7) 4 (4.3) 42 (91.3) 4 (8.7) 0 (0.0)

TNF-alpha -376G>A (rs1800750) polymorphism

Allele frequencies, n (%) Genotype frequencies, n (%)

Author Gender Disease status Study size HWE G A GG GA AA

Schürks 2009 (17) all/females controls 20,425 0.002 40,283 (98.6) 567 (1.4) 19,869 (97.3) 545 (2.7) 11 (0.1)
migraine 4578 0.307 9012 (98.4) 144 (1.6) 4436 (96.9) 140 (3.1) 2 (0.04)
MA 1276 0.374 2504 (98.1) 48 (1.9) 1229 (96.3) 46 (3.6) 1 (0.1)
MO 1951 1.000 3851 (98.7) 51 (1.3) 1900 (97.4) 51 (2.6) 0 (0.0)

Pappa 2010 (22) all controls 178 --- 356 (100.0) 0 (0.0) 178 (100.0) 0 (0.0) 0 (0.0)
MO 103 1.000 205 (99.5) 1 (0.5) 102 (99.0) 1 (1.0) 0 (0.0)

females controls 60 --- 120 (100) 0 (0.0) 60 (100) 0 (0.0) 0 (0.0)
MO 57 1.000 113 (99.1) 1 (0.9) 56 (98.2) 1 (1.8) 0 (0.0)

males controls 118 --- 236 (100) 0 (0.0) 118 (100) 0 (0.0) 0 (0.0)
MO 46 --- 92 (100) 0 (0.0) 46 (100) 0 (0.0) 0 (0.0)

TNF: tumor necrosis factor; HWE: p value from exact test for the Hardy-Weinberg Equilibrium; MA: migraine with aura; MO: migraine without aura.